Bloomberg Intelligence cover image

Kimberly-Clark to Buy Tylenol Maker Kenvue for $40 Billion

Bloomberg Intelligence

00:00

Leadership Transition and Capital Strategy at Berkshire

Paul asks whether Greg Abel will change capital allocation and Matthew outlines possible steady buybacks and special dividends.

Play episode from 20:54
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app